Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Jul. 01, 2023
Jul. 02, 2022
OPERATING ACTIVITIES    
Net loss $ (57,425) $ (55,960)
Adjustments to reconcile net loss to cash provided (used) by operating activities:    
Depreciation and amortization 67,075 66,754
Reduction in the carrying amount of right-of-use assets 95,728 93,337
Stock-based compensation 15,784 22,297
Provision for doubtful accounts 4,633 899
Pension expense in excess of (less than) contributions (10,661) 89,277
Other, net 10,645 6,813
Changes in operating assets and liabilities:    
Accounts receivable 395,110 174,125
Inventories (493,720) (961,113)
Accounts payable 344,482 471,065
Income taxes (30,667) (70,727)
Accrued liabilities (66,581) (94,746)
Operating lease right-of-use assets and liabilities (102,688) (93,734)
Other assets and liabilities (8,140) (6,607)
Cash provided (used) by operating activities 163,575 (358,320)
INVESTING ACTIVITIES    
Capital expenditures (61,763) (52,657)
Software purchases (22,827) (26,907)
Other, net (5,972) 10,045
Cash used by investing activities (90,562) (69,519)
FINANCING ACTIVITIES    
Contingent consideration payment 0 (56,976)
Net increase in short-term borrowings 47,029 491,917
Payments on long-term debt (268) (500,261)
Payment of debt issuance costs (346) 0
Cash dividends paid (116,575) (194,135)
Proceeds from issuance of Common Stock, net of (payments) for tax withholdings (1,725) (1,766)
Cash used by financing activities (71,885) (261,221)
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash (9,326) (58,988)
Net change in cash, cash equivalents and restricted cash (8,198) (748,048)
Cash, cash equivalents and restricted cash – beginning of year 816,319 1,277,082
Cash, cash equivalents and restricted cash – end of period $ 808,121 $ 529,034